JM4 Activators are a class of chemical compounds that enhance the functional activity of JM4, a protein known for its role in cellular processes such as intracellular trafficking. Some JM4 activators, such as LFA-1 Activator, PMA, and Sodium orthovanadate, directly influence JM4's interactions or post-translational modifications. PMA, a PKC activator, enhances JM4 activity by promoting PKC-dependent phosphorylation of JM4. Sodium orthovanadate, a phosphatase inhibitor, enhances JM4 activity by preventing dephosphorylation of JM4.
Other JM4 activators function by impacting the cellular signaling pathways involved in the regulation of JM4. For instance, PGE2, Forskolin, and PIP2 activate pathways that lead to the upregulation of JM4. PGE2 activates EP2 and EP4 receptors, Forskolin activates adenylate cyclase, and PIP2 activates phospholipase C. Each of these activations results in the productionof specific secondary messengers like cAMP, IP3, and DAG that are known to upregulate JM4. On the other hand, chemicals like Ionomycin, Anandamide, Acetylcholine, Epinephrine, and Muscarine influence the functional activity of JM4 by increasing intracellular calcium levels or activating specific receptors that can lead to the enhancement of JM4 activity. For example, Ionomycin increases intracellular calcium, a known cofactor for the activation of JM4, while Anandamide, Acetylcholine, Epinephrine, and Muscarine activate cannabinoid, muscarinic acetylcholine, and beta-adrenergic receptors, respectively, which subsequently enhance JM4 activity. Another compound, Leukotriene B4, binds to the BLT1 receptor, a process that can also lead to increased JM4 activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. PKC is known to phosphorylate JM4, leading to its activation. By activating PKC, PMA can enhance the functional activity of JM4. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 is known to activate EP2 and EP4 receptors, which are known to upregulate JM4 via a cAMP-dependent pathway. By activating these receptors, PGE2 can enhance the functional activity of JM4. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, which increases intracellular cAMP levels. cAMP is known to upregulate JM4, and by increasing cAMP, Forskolin can enhance the functional activity of JM4. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore. Calcium is known to be a cofactor for the activation of JM4, and by increasing intracellular calcium, Ionomycin can enhance the functional activity of JM4. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a phosphatase inhibitor. Phosphatases are known to dephosphorylate JM4, and by inhibiting their activity, Sodium orthovanadate can enhance the functional activity of JM4. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
LTB4 is known to bind to the BLT1 receptor, which can lead to the enhancement of JM4 activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is known to bind to beta-adrenergic receptors, which are known to upregulate JM4. By activating these receptors, Epinephrine can enhance the functional activity of JM4. | ||||||